Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy

Horm Metab Res. 2008 Mar;40(3):163-4. doi: 10.1055/s-2008-1042425. Epub 2008 Feb 6.

Authors

D Pitocco¹, M C Collina, T Musella, V Ruotolo, S Caputo, A Manto, P Caradonna, M Galli, L Mancini, G Ghirlanda

Affiliation

¹ Internal Medicine Institute, Catholic University, L. go A. Gemelli 8, Rome, Italy. dario.pitocco@rm.unicatt.it

PMID: 18256973
DOI: 10.1055/s-2008-1042425

No abstract available

Publication types

Review

MeSH terms

Acute Disease
Alendronate / therapeutic use*
Arthropathy, Neurogenic / drug therapy*
Arthropathy, Neurogenic / metabolism
Bone Density Conservation Agents / therapeutic use*
Bone Resorption / drug therapy*
Diabetic Neuropathies / drug therapy*
Diabetic Neuropathies / metabolism
Humans
Inflammation
Insulin-Like Growth Factor I / metabolism*

Substances

Bone Density Conservation Agents
Insulin-Like Growth Factor I
Alendronate